These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9076837)
1. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Scaglione F Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S56-9. PubMed ID: 9076837 [TBL] [Abstract][Full Text] [Related]
2. Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid. Sawchuk RJ; Cheung BW; Ji P; Cartier LL Pharmacotherapy; 2005 Dec; 25(12 Pt 2):140S-145S. PubMed ID: 16305284 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of antibiotics in children. Toyonaga Y Acta Paediatr Jpn; 1997 Feb; 39(1):114-23. PubMed ID: 9124043 [TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection. Frimodt-Møller N Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588 [TBL] [Abstract][Full Text] [Related]
5. Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure? Bergogne-Bérézin E J Antimicrob Chemother; 1995 Mar; 35(3):363-71. PubMed ID: 7782252 [TBL] [Abstract][Full Text] [Related]
8. The new antibiotics. Birnbaumer D; Fernández-Frackelton M Emerg Med Clin North Am; 2000 Nov; 18(4):671-708. PubMed ID: 11130933 [TBL] [Abstract][Full Text] [Related]
9. [Monitoring of antibiotic treatment of patient with a severe bacterial infection]. Aubert G; Carricajo A Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. McKinnon PS; Paladino JA; Schentag JJ Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273 [TBL] [Abstract][Full Text] [Related]
11. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics. Mattie H Scand J Infect Dis Suppl; 1990; 74():133-6. PubMed ID: 2129065 [TBL] [Abstract][Full Text] [Related]
18. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. Segreti J; Jones RN; Bertino JS J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341 [TBL] [Abstract][Full Text] [Related]
19. The use of beta-lactam antibiotics in infections--an overview. Quintiliani R Scand J Infect Dis Suppl; 1984; 42():99-109. PubMed ID: 6597565 [TBL] [Abstract][Full Text] [Related]
20. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis. Nomura K; Morikawa N; Ikawa K; Ikeda K; Fujimoto Y; Shimizu D; Taniguchi K; Shimura K; Kanbayashi Y; Komori T; Matsumoto Y; Fujita N; Shimazaki C; Taniwaki M J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]